These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34935238)

  • 1. Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational report.
    Rogenhofer N; Mahner S; von Hasselbach YL; Thaler CJ
    Am J Reprod Immunol; 2022 Feb; 87(2):e13506. PubMed ID: 34935238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sera of patients with recurrent miscarriages containing anti-trophoblast antibodies (ATAB) reduce hCG and progesterone production in trophoblast cells in vitro.
    von Schönfeldt V; Rogenhofer N; Ruf K; Thaler CJ; Jeschke U
    J Reprod Immunol; 2016 Sep; 117():52-6. PubMed ID: 27472296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti α-enolase antibody is a novel autoimmune biomarker for unexplained recurrent miscarriages.
    Ye Y; Kuhn C; Kösters M; Arnold GJ; Ishikawa-Ankerhold H; Schulz C; Rogenhofer N; Thaler CJ; Mahner S; Fröhlich T; Jeschke U; von Schönfeldt V
    EBioMedicine; 2019 Mar; 41():610-622. PubMed ID: 30827932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of polyvalent immunoglobulins in patients with recurrent pregnancy loss and antibodies to the choriocarcinoma cell line JEG-3.
    Rogenhofer N; von Schönfeldt V; Ochsenkühn R; Sili F; Thaler CJ
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():161-7. PubMed ID: 26407335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
    Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
    Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
    Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
    Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
    Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralipid treatment for women with reproductive failures.
    Coulam CB
    Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion.
    Meng L; Lin J; Chen L; Wang Z; Liu M; Liu Y; Chen X; Zhu L; Chen H; Zhang J
    Arch Gynecol Obstet; 2016 Jul; 294(1):29-39. PubMed ID: 26671484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralipid therapy and adverse reproductive outcome: is there any evidence?
    Kumar P; Marron K; Harrity C
    Reprod Fertil; 2021 Jul; 2(3):173-186. PubMed ID: 35118388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of low-dose ovarian stimulation with HMG plus progesterone on pregnancy outcome in women with history of recurrent pregnancy loss and secondary infertility: a retrospective cohort study.
    Coccia ME; Rizzello F; Cozzolino M; Turillazzi V; Capezzuoli T
    Gynecol Endocrinol; 2018 Jun; 34(6):528-531. PubMed ID: 29433402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.
    Shahine LK; Marshall L; Lamb JD; Hickok LR
    Fertil Steril; 2016 Oct; 106(5):1124-1128. PubMed ID: 27371114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study.
    Bhatt SJ; Marchetto NM; Roy J; Morelli SS; McGovern PG
    Hum Reprod; 2021 Jul; 36(8):2339-2344. PubMed ID: 34027546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear Antibodies predict a higher number of Pregnancy Loss in Unexplained Recurrent Pregnancy Loss.
    Sakthiswary R; Rajalingam S; Norazman MR; Hussein H
    Clin Ter; 2015; 166(2):e98-101. PubMed ID: 25945451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Study on the Expression of G-CSF, G-CSFR, VEGF, VEGFR-1, Foxp3 in First Trimester Trophoblast of Recurrent Pregnancy Loss in Pregnancies Treated with G-CSF and Controls.
    Scarpellini F; Klinger FG; Rossi G; Sbracia M
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing of products of conception in recurrent pregnancy loss evaluation.
    Dahdouh EM; Kutteh WH
    Reprod Biomed Online; 2021 Jul; 43(1):120-126. PubMed ID: 33926784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
    Yang X; Meng T
    J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent pregnancy loss and obesity.
    Sugiura-Ogasawara M
    Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):489-97. PubMed ID: 25589398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.